Inflammation modulates anxiety in an animal model of multiple sclerosis

Behavioural Brain Research

Volumn 220, Issue 1, 2011, Pages 20-29

  Peruga, Isabella ^a   Hartwig, Silvia ^b   Thöne, Jan ^a   Hovemann, Bernhard ^b   Gold, Ralf ^a   Juckel, Georg ^b   Linker, Ralf A ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Anxiety; Depressive like behavior; Experimental autoimmune encephalomyelitis; Hippocampus; Neurotransmitter

Indexed keywords

AMITRIPTYLINE; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR CHANGE; CELL LOSS; CHRONIC INFLAMMATION; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; EMOTIONALITY; FEMALE; HIPPOCAMPUS; LEARNED HELPLESSNESS; LIGHT DARK BOX; MONOAMINERGIC SYSTEM; MOTOR PERFORMANCE; MOUSE; MULTIPLE SCLEROSIS; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN BRAIN LEVEL; OPEN FIELD TEST; PREPULSE INHIBITION; PRIORITY JOURNAL; ROTAROD TEST; STARTLE REFLEX; TISSUE LEVEL;

ACOUSTIC STIMULATION; AMITRIPTYLINE; ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY; CENTRAL NERVOUS SYSTEM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOKINES; DARK ADAPTATION; DEMYELINATING DISEASES; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; FEMALE; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HELPLESSNESS, LEARNED; INFLAMMATION; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MULTIPLE SCLEROSIS; PEPTIDE FRAGMENTS; PERTUSSIS TOXIN; PHOSPHOPYRUVATE HYDRATASE; PSYCHOACOUSTICS; ROTAROD PERFORMANCE TEST; STARTLE REACTION; STEREOTAXIC TECHNIQUES; TIME FACTORS;

EID: 79751536286     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.01.018     Document Type: Article

References (38)

1. Rost K. Disability from depression: the public health challenge to primary care. Nord J Psychiatry 2009, 63:17-21.
2. Kendler K.S., Kessler R.C., Walters E.E., MacLean C., Neale M.C., Heath A.C., et al. Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry 1995, 152:833-842.
3. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
4. Schiffer R.B., Babigian H.M. Behavioral disorders in multiple sclerosis, temporal lobe epilepsy, and amyotrophic lateral sclerosis. An epidemiologic study. Arch. Neurol 1984, 41:1067-1069.
5. Schubert D.S., Foliart R.H. Increased depression in multiple sclerosis patients. A meta-analysis. Psychosomatics 1993, 34:124-130.
6. Chwastiak L., Ehde D.M., Gibbons L.E., Sullivan M., Bowen J.D., Kraft G.H. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry 2002, 159:1862-1868.
7. Joffe R.T. Depression and multiple sclerosis: a potential way to understand the biology of major depressive illness. J Psychiatry Neurosci 2005, 30:9-10.
8. Anisman H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci 2009, 34:4-20.
9. Marik C., Felts P.A., Bauer J., Lassmann H., Smith K.J. Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?. Brain 2007, 130:2800-2815.
10. Sandyk R. Serotonergic neuronal atrophy with synaptic inactivation, not axonal degeneration, are the main hallmarks of multiple sclerosis. Int J Neurosci 1998, 95:133-140.
11. Sandyk R., Awerbuch G.I. The co-occurrence of multiple sclerosis and migraine headache: the serotoninergic link. Int J Neurosci 1994, 76:249-257.
12. Litteljohn D., Mangano E., Shukla N., Hayley S. Interferon-gamma deficiency modifies the motor and co-morbid behavioral pathology and neurochemical changes provoked by the pesticide paraquat. Neuroscience 2009, 164:1894-1906.
13. Gold R., Linington C., Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006, 129:1953-1971.
14. Vogt J., Paul F., Aktas O., Müller-Wielsch K., Dörr J., Dörr S., et al. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann Neurol 2009, 66:310-322.
15. Herrero-Herranz E., Pardo L.A., Gold R., Linker R.A. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neurobiol Dis 2008, 30:162-173.
16. Olsson T. Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurology 1995, 45:S11-15.
17. Pollak Y., Orion E., Goshen I., Ovadia H., Yirmiya R. Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of 'depression due to multiple sclerosis'. Brain, Behav. Immun. 2002, 16:533-543.
18. Pollak Y., Ovadia H., Goshen I., Gurevich R., Monsa K., Avitsur R., et al. Behavioral aspects of experimental autoimmune encephalomyelitis. J Neuroimmunol 2000, 104:31-36.
19. Linker R.A., Mäurer M., Gaupp S., Martini R., Holtmann B., Giess R., et al. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat Med 2002, 8:620-624.
20. Crawley J.N. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 1999, 835:18-26.
21. Winter B., Juckel G., Viktorov I., Katchanov J., Gietz A., Sohr R., et al. Anxious and hyperactive phenotype following brief ischemic episodes in mice. Biol Psychiatry 2005, 57:1166-1175.
22. Klein J., Winter C., Coquery N., Heinz A., Morgenstern R., Kupsch A., et al. Lesion of the medial prefrontal cortex and the subthalamic nucleus selectively affect depression-like behavior in rats. Behav Brain Res 2010, 213:73-81.
23. Chourbaji S., Zacher C., Sanchis-Segura C., Dormann C., Vollmayr B., Gass P. Learned helplessness: validity and reliability of depressive-like states in mice. Brain Res Brain Res Protoc 2005, 16:70-78.
24. Engin E., Treit D. The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus. Behav Pharmacol 2007, 18:461-470.
25. Frodl T., Meisenzahl E.M., Zetzsche T., Born C., Groll C., Jäger M., et al. Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry 2002, 159:1112-1118.
26. Liu G., Cai G., Cai Y., Sheng Z., Jiang J., Mei Z., et al. Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1. Neuropsychopharmacology 2007, 32:1531-1539.
27. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009, 65:732-741.
28. Smorodchenko A., Wuerfel J., Pohl E.E., Vogt J., Tysiak E., Glumm R., et al. CNS-irrelevant T-cells enter the brain, cause blood-brain barrier disruption but no glial pathology. Eur J Neurosci 2007, 26:1387-1398.
29. Braff D.L., Geyer M.A., Light G.A., Sprock J., Perry W., Cadenhead K.S., et al. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophrenia Res 2001, 49:171-178.
30. Popova N.K., Naumenko V.S., Tibeikina M.A., Kulikov A.V. Serotonin transporter, 5-HT1A receptor, and behavior in DBA/2J mice in comparison with four inbred mouse strains. J Neurosci Res 2009, 87:3649-3657.
31. Quednow B.B., Westheide J., Kühn K., Werner P., Maier W., Hawellek B., et al. Normal prepulse inhibition and habituation of acoustic startle response in suicidal depressive patients without psychotic symptoms. J Affec Disord 2006, 92:299-303.
32. Ziehn M.O., Avedisian A.A., Tiwari-Woodruff S., Voskuhl R.R. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE. Lab Invest 2010, 90:774-786.
33. Mangiardi M, Crawford DK, Xia X, Du S, Simon-Freeman R, Voskuhl RR, et al. An animal model of cortical and callosal pathology in multiple sclerosis. Brain Pathol, in press. doi:10.1111/j.1750-3639.2010.00444.x.
34. Okuda Y., Sakoda S., Bernard C.C., Yanagihara T. The development of autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein is associated with an upregulation of both proinflammatory and immunoregulatory cytokines in the central nervous system. J Interferon Cytokine Res 1998, 18:415-421.
35. Anisman H., Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann Med 2003, 35:2-11.
36. Patel B.A., Arundell M., Parker K.H., Yeoman M.S., O'Hare D. Simple and rapid determination of serotonin and catecholamines in biological tissue using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Analyt Technol Biomed Life Sci 2005, 818:269-276.
37. Zhu C., Blakely R.D., Hewlett W.A. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 2006, 31:2121-2131.
38. Rajda C., Bencsik K., Vécsei L.L., Bergquist J. Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patients. J Neuroimmunol 2002, 124:93-100.